Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · IEX Real-Time Price · USD
15.81
-0.21 (-1.31%)
At close: May 10, 2024, 4:00 PM
15.50
-0.31 (-1.96%)
After-hours: May 10, 2024, 5:09 PM EDT
Contineum Therapeutics Revenue
In the year 2023, Contineum Therapeutics had annual revenue of $50.00M.
Revenue (ttm)
$50.00M
Revenue Growth
n/a
P/S Ratio
7.95
Revenue / Employee
$1,612,903
Employees
31
Market Cap
397.32M
Revenue Chart
* The company reports in USD currency but revenue data is shown in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 50.00M | - | - |
| Dec 31, 2022 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCTNM News
- 5 weeks ago - Contineum Therapeutics Announces Pricing of Initial Public Offering - GlobeNewsWire
- 2 months ago - Neuroscience and inflammation biotech Contineum Therapeutics files for a $150 million IPO - Renaissance Capital
- 2 months ago - Contineum Therapeutics IPO Registration Document (S-1) - SEC